TLX telix pharmaceuticals limited

1.00%

$24.19

what the article indicates however is platinum supports the...

First 4 Last

Share
Profile

Follow
Werble

1,165 Posts.

163

10/01/24

22:40

Post #: 71821849
Share

Originally posted by ajostu: ↑

So I read that, and honestly, if it's supposed to make a compelling case for the NASDAQ move, I wasn't convinced.

It probably reads OK to people who don't know the company, but it really doesn't say what the benefit would be. "Will it raise capital" asks the article and if so how much?"

Wrong question, people: the question is "what for?"

Let me put on my Eddy De Bono Black Hat and play devil's advocate, and maybe ask the sort of questions that someone might ask if they're not just writing a puff piece.

The company sells itself- and prides itself- on being self funding. Given that the revenue is likely to increase substantially within the next two years, is any sort of raise really necessary? I know Prostact will be expensive but surely the company can cover that.

It is not clear to me that the factors limiting to the speed of implementing the therapeutics program are simply a matter of access to capital. There look to be limits in the availability of expertise and of test subjects. These can maybe be ameliorated by going to multiple sites (which they'll be doing with Prostact) but there are risks and potential inefficiencies that go with that.

If they raise because it gives them further opportunities that's one thing. If they raise because "it will make the current program go faster" then I'm not convinced.

Given that the company has had no trouble dealing with the big cheeses (Lilly) and doing deals on smaller companies (or buying them outright) do they need to go to the US to make deals? And surely it wouldn't be needed for better clinical/ scientific access, that seems to be going just fine.

If the company is looking to get bought out (though hopefully at a higher price than the examples given in the article) does being in the US really matter? It's not like foreign companies have difficulties buying Australian.

Look, maybe going to the NASDAQ is a good idea, but maybe it's a testament to the quality(?) of Australian mainstream financial journalism that I'm now much more negatively disposed to the idea than before.

Expand

what the article indicates however is platinum supports the move. from everyone I have spoken to Bianca Ogden is one of the smartest biotech capital managers around...

TLX Price at posting: $9.78 Sentiment: Buy Disclosure: Held
6 Upvote

2 Great analysis

Reply

Top Stories

OSL

OncoSil wraps up recruitment for key pancreatic cancer trial

THL

Tourism Holdings says Liberation Day tariffs smashed US RV demand

Week 27 Wrap: 40% China tariffs?; ASX +10% FY25; US Amazon price spike

AII

Inside the Depths of Panasqueira: A Legacy Carved in Rock

KGD

Kula picks up unexplored niobium play in Malawi, with surface samples logged

DMP

Is Domino's a steal after -25% plunge?

Listen: HotCopper Wire Podcast 016 – FY25 ended up not so bad... but Trump unpause is coming

NMG

New Murchison Gold blasts off at Crown Prince as 'better than expected' results return

HotCopper Highlights, Week 27: G8 scalped, Domino’s drops the box, Gemlife brief hype & more

Trump chides Powell as Goldman call for calm. The RBA must be nervous

First 4 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $24.19		Change 0.240(1.00%)		Mkt cap ! $8.185B

Open	High	Low	Value	Volume
$24.20	$24.43	$23.92	$22.11M	913.3K

Buyers (Bids)

No.	Vol.	Price($)
2	2808	$24.15

Sellers (Offers)

Price($)	Vol.	No.
$24.24	3000	1

View Market Depth

No.	Vol.	Price($)
2	2808	24.150
1	41	24.140
1	500	24.120
1	40	24.100
1	1000	24.020

Price($)	Vol.	No.
24.300	15204	2
24.350	2645	2
24.360	1936	2
24.380	1030	3
24.400	2150	2

Last trade - 16.10pm 04/07/2025 (20 minute delay)

TLX (ASX) Chart

what the article indicates however is platinum supports the...

OncoSil wraps up recruitment for key pancreatic cancer trial

Tourism Holdings says Liberation Day tariffs smashed US RV demand

Week 27 Wrap: 40% China tariffs?; ASX +10% FY25; US Amazon price spike

Inside the Depths of Panasqueira: A Legacy Carved in Rock

Kula picks up unexplored niobium play in Malawi, with surface samples logged

Is Domino's a steal after -25% plunge?

Listen: HotCopper Wire Podcast 016 – FY25 ended up not so bad... but Trump unpause is coming

New Murchison Gold blasts off at Crown Prince as 'better than expected' results return

HotCopper Highlights, Week 27: G8 scalped, Domino’s drops the box, Gemlife brief hype & more

Trump chides Powell as Goldman call for calm. The RBA must be nervous

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

what the article indicates however is platinum supports the...

Top Stories

OncoSil wraps up recruitment for key pancreatic cancer trial

Tourism Holdings says Liberation Day tariffs smashed US RV demand

Week 27 Wrap: 40% China tariffs?; ASX +10% FY25; US Amazon price spike

Inside the Depths of Panasqueira: A Legacy Carved in Rock

Kula picks up unexplored niobium play in Malawi, with surface samples logged

Is Domino's a steal after -25% plunge?

Listen: HotCopper Wire Podcast 016 – FY25 ended up not so bad... but Trump unpause is coming

New Murchison Gold blasts off at Crown Prince as 'better than expected' results return

HotCopper Highlights, Week 27: G8 scalped, Domino’s drops the box, Gemlife brief hype & more

Trump chides Powell as Goldman call for calm. The RBA must be nervous

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News